$15.68 0.98 (+6.67%)
2/13/2012 4:00 PM

Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 3 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

1
Player Avatar ImmortalThanos (< 20) Submitted: 2/28/2008 11:26:10 AM : Underperform Start Price: $22.02 LGND Score: +38.26

Avoid this like the plague. This is another one of those "Jack Of All Trades" companies that never really gets anywhere. Skip this until they get a better mission statement developed.

Report this Post Add Comment

Featured Broker Partners


Advertisement